Rebekka M. Ortiz
Tampere University Hospital(FI)Tampere University(FI)
Publications by Year
Research Areas
Neurological disorders and treatments, HER2/EGFR in Cancer Research, Cell Adhesion Molecules Research, Botulinum Toxin and Related Neurological Disorders, Genetic Neurodegenerative Diseases
Most-Cited Works
- → Shedding light on ADAM metalloproteinases(2005)449 cited
- → ADAM-9, ADAM-15, and ADAM-17 are upregulated in macrophages in advanced human atherosclerotic plaques in aorta and carotid and femoral arteries—Tampere vascular study(2009)82 cited
- → Fecal Microbiota Transplantation for Treatment of Parkinson Disease(2024)80 cited
- → Alternative splicing of ADAM15 regulates its interactions with cellular SH3 proteins(2009)37 cited
- → Aberrant alternative exon use and increased copy number of human metalloprotease‐disintegrin ADAM15 gene in breast cancer cells(2004)35 cited
- → ADAM15 gene structure and differential alternative exon use in human tissues(2007)32 cited
- → The prevalence of adult-onset isolated dystonia in Finland 2007-2016(2018)30 cited
- → Comorbidity and retirement in cervical dystonia(2019)25 cited
- → ADAM9, ADAM10, and ADAM15 mRNA levels in the rat brain after kainic acid-induced status epilepticus(2005)18 cited
- → Deep brain stimulation for dystonia in Finland during 2007–2016(2019)11 cited